Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

209
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
209
Biological Effects of Radiation02:59

Biological Effects of Radiation

16.4K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
16.4K
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

43
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
43
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

4.2K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
4.2K
Cancer Survival Analysis01:21

Cancer Survival Analysis

482
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
482
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

39
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
39

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of Widely Available and Easy-to-Prepare Solutions for Skin Decontamination with Manganese-56 Chloride and Oxide as Models for Water-Soluble and Insoluble Radioactive Compounds.

Radiation research·2026
Same author

Factors Influencing Double-Strand Break Focus Biodosimetry for Detection of Internal Low-LET Irradiation in Human Blood Samples.

Radiation research·2026
Same author

Establishment of Dicentric Chromosome Analysis for Individual Radiation Biodosimetry in MIDI Format.

Radiation research·2026
Same author

National Institute of Allergy and Infectious Diseases (NIAID) - Bundeswehr Institute of Radiobiology (BIR) Joint Programmatic Workshop on a Global Approach to Medical Countermeasure Development in Radiological Public Health Preparedness.

Radiation research·2026
Same author

Case Report: The Limited Value of Dicentric Analysis in Cases of Suspected Overexposure to a Low X-ray Dose.

Radiation research·2026
Same author

Cytokine use in the hematopoietic subsyndrome of acute radiation syndrome (H-ARS): implications for the role of cytokines in a mass casualty radiologic/nuclear (R/N) emergency.

Journal of radiological protection : official journal of the Society for Radiological Protection·2026

Related Experiment Video

Updated: Oct 27, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.9K

Early-response multiple-parameter biodosimetry and dosimetry: risk predictions.

William F Blakely1, Matthias Port2, Michael Abend2

  • 1Scientific Research Department, Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD, United States of America.

Journal of Radiological Protection : Official Journal of the Society for Radiological Protection
|July 19, 2021
PubMed
Summary

A comprehensive approach to radiation biodosimetry and dosimetry assessment is crucial for high-dose exposures. Integrated methods, including clinical signs and biomarkers, aid in early injury prediction and medical management.

Keywords:
acute radiation syndrome (ARS) severitybiodosimetryblood chemistryclinical signs and symptomscytogenetic dose assessmentphysical dosimetryradioactivity contamination

More Related Videos

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.4K
An Automated Microscopic Scoring Method for the γ-H2AX Foci Assay in Human Peripheral Blood Lymphocytes
08:23

An Automated Microscopic Scoring Method for the γ-H2AX Foci Assay in Human Peripheral Blood Lymphocytes

Published on: December 25, 2021

5.0K

Related Experiment Videos

Last Updated: Oct 27, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.9K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.4K
An Automated Microscopic Scoring Method for the γ-H2AX Foci Assay in Human Peripheral Blood Lymphocytes
08:23

An Automated Microscopic Scoring Method for the γ-H2AX Foci Assay in Human Peripheral Blood Lymphocytes

Published on: December 25, 2021

5.0K

Area of Science:

  • Radiation biology
  • Medical physics
  • Toxicology

Background:

  • High-dose radiation exposure necessitates rapid and accurate biodosimetry and dosimetry.
  • Existing methods require integration for effective emergency response.
  • Early assessment is vital for guiding medical management strategies.

Purpose of the Study:

  • To outline a comprehensive, multi-parameter approach for assessing high-dose radiation exposure.
  • To emphasize the integration of various biodosimetry and dosimetry techniques.
  • To highlight the utility of early-phase diagnostics for predicting radiation injury severity.

Main Methods:

  • Measuring radioactivity, observing clinical signs/symptoms, and serial blood counts.
  • Utilizing cytogenetic bioassays (dicentric assay, premature chromosome condensation assay).
  • Employing proteomic biomarkers, gene expression assays, and physical dose reconstruction.

Main Results:

  • An integrated biodosimetry/dosimetry concept of operations is proposed for radiological emergencies.
  • Early-phase diagnostics using clinical signs, symptoms, blood chemistry biomarkers, and triage cytogenetics demonstrate predictive utility.
  • Combined biological, clinical, and physical dosimetry provides early diagnostics and definitive dose/injury assessment.

Conclusions:

  • A multifaceted biodosimetry and dosimetry strategy is essential for managing life-threatening radiation exposures.
  • Integrated approaches enhance early-phase diagnostics to guide medical management.
  • Early clinical and biological markers effectively predict acute radiation injury severity.